AbbVie Inc. (ABBV) vs Thermo Fisher Scientific Inc. (TMO)
A side-by-side comparison of AbbVie Inc. and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.
ABBV
AbbVie Inc.
$263.58HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT
TMO
Thermo Fisher Scientific Inc.
$576.46HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT
Total return — ABBV vs TMO
growth of $100 · dividends reinvested · last 14yABBV +1197.1%TMO +853.4%ABBV compounded faster
ABBV TMO
ABBV vs TMO: by the numbers
- •ABBV is the larger company ($465.69B vs $214.22B market cap).
- •TMO trades at the lower trailing earnings multiple (31.01 vs 129.20 P/E), one valuation lens rather than an overall verdict.
- •TMO converts more revenue to profit (15.06% vs 5.79% net margin).
- •TMO grew revenue faster over the past five years (5.00% vs 4.59% CAGR).
- •ABBV pays the higher dividend yield (2.56% vs 0.31%).
Metrics side by side
Valuation
| Metric | ABBV | TMO |
|---|---|---|
| P/E ratio | 129.20 | 31.01 |
| Forward P/E | N/A | 23.01 |
| P/S ratio | 7.44 | 4.62 |
| P/B ratio | 17.00 | 4.06 |
| PEG ratio | N/A | 4.54 |
| EV / EBITDA | 20.92 | 24.03 |
| FCF yield | 4.46% | 3.42% |
Profitability
| Metric | ABBV | TMO |
|---|---|---|
| Gross margin | 70.68% | 40.37% |
| Operating margin | 27.60% | 17.69% |
| Net margin | 5.79% | 15.06% |
| ROE | 13.23% | 13.24% |
| ROIC | 12.97% | 7.58% |
Dividends
| Metric | ABBV | TMO |
|---|---|---|
| Dividend yield | 2.56% | 0.31% |
| Payout ratio | 284.39% | 10.13% |
Growth (annualized)
| Metric | ABBV | TMO |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 5.00% |
| EPS CAGR (5Y) | -2.79% | 1.99% |
| FCF CAGR (5Y) | 3.24% | -1.83% |
| Total return CAGR (5Y) | 21.73% | 2.05% |
Frequently asked
- Which has the lower trailing P/E, ABBV or TMO?
- TMO has the lower trailing P/E: ABBV trades at 129.20 and TMO at 31.01. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or TMO?
- Over the past five years, TMO grew revenue faster — ABBV at a 4.59% CAGR versus TMO at 5.00%.
- Does ABBV or TMO pay a bigger dividend?
- ABBV yields 2.56% and TMO yields 0.31% based on trailing dividends and the latest price.
- Is ABBV or TMO more profitable?
- TMO runs the higher net margin — ABBV at 5.79% versus TMO at 15.06%.
- How have ABBV and TMO total returns compared?
- Over the past 10 years, ABBV delivered 19.90% and TMO delivered 14.09% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioThermo Fisher Scientific P/E ratioAbbVie dividend yieldThermo Fisher Scientific dividend yieldAbbVie ROEThermo Fisher Scientific ROEAbbVie operating marginThermo Fisher Scientific operating marginAbbVie revenue growthThermo Fisher Scientific revenue growthAbbVie free cash flowThermo Fisher Scientific free cash flow
AbbVie & Thermo Fisher Scientific appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.